Cellenion, a SCIENION company, offers solutions and technologies for controlled cell dispensing with applications in the fields of bioprinting and single-cell isolation.
Ability to manipulate single-cell has long been a challenge for the scientific community due to their micrometric size and delicate nature. Cellenion has developed and patented a breakthrough technology called cellenONE® allowing high throughput isolation and dispensing of single-cell onto a wide range of substrates. Read more
cellenONE® technology is able to handle low cell sample volume, keeping high cell viability and isolating very precisely single cells for cell line development and sequencing among other applications.
Bioprinting is the process of generating spatially-controlled cell patterns using 3D printing technologies. Cellenion will aim toward both miniaturization and automation in order to produce reproducible models of different complexities. Read more
cellenion´s innovative technology has been presented and published at transkript, a leading German-speaking news magazine for biotechnology and life sciences.Read more
Joint forces to isolate cells contained in pleural fluid of cancer patients with cellenONE technology and Centre Léon Bérard à Lyon. PELICAN project awarded by the Cancérolopôle Lyon Auvergne Rhône-Alpes.Read more
Our popular sell-out event will be held again in Berlin this year. Hold the dates of September 06-07, 2018. More info coming soon.Read more
Cellenion gave a company presentation at the BlueSky Meetings during the 10th Edition of the Journées Collaboratives in Grenoble, France.Read more